Founders Fund-backed company announces 5 senior hires with domain experience from publicly traded companies including Veeva Systems, Salesforce, ICON and Munich Re Teckro, the company transforming clinical trials for the world’s leading pharmaceutical and...
Top-line Data Readout Remains on Track for early Q4 2019 Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases, today...
Calithera Biosciences, Inc. (CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the treatment of cancer and other life-threatening diseases, today announced treatment of the first patient in a Phase 1/2...
Trial Designed to Test Camsirubicin Against Doxorubicin as First-Line Therapy Monopar Therapeutics Inc., an oncology-focused biopharmaceutical company, and the Spanish Sarcoma Group (Grupo Español de Investigación en Sarcomas, or GEIS) today announced that they have...
On the forefront of the gene therapy industry, AskBio celebrates the accomplishments of all companies for their work in finding curative therapies for life-threatening diseases. Pfizer reported results from a Phase 1b clinical trial of PF-06939926, its investigational...
Unum Therapeutics Inc. (UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies to treat cancer based on its novel T cell technology platforms, today announced that the U.S. Food and Drug Administration (FDA) has...
Email
Text